• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似肝素诱导血小板减少症中国患者中肝素诱导血小板减少症专家概率和 4T 评分的前瞻性评估。

Prospective evaluation of heparin-induced thrombocytopenia expert probability and 4T scores in Chinese patients with suspected heparin-induced thrombocytopenia.

机构信息

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

出版信息

Chin Med J (Engl). 2019 Jun 20;132(12):1441-1447. doi: 10.1097/CM9.0000000000000261.

DOI:10.1097/CM9.0000000000000261
PMID:31205102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6629329/
Abstract

BACKGROUND

Diagnosis of heparin-induced thrombocytopenia (HIT) is challenging. This study aimed to compare the diagnostic performance of HIT expert probability (HEP) and 4T scores, and to evaluate the inter-observer reliability for the 4T score in a clinical setting.

METHODS

This prospective study included HIT-suspected patients between 2016 and 2018. Three hematologists assessed the HEP and 4T scores. Correlations between scores and anti-platelet factor 4 (anti-PF4)/heparin antibodies were evaluated. Receiver operating characteristic curves and area under the curve (AUC) were used to assess the predictive accuracy of these two scoring models. The intraclass correlation coefficient (ICC) was used to assess the inter-observer agreement of 4T scores between residents and hematologists.

RESULTS

Of the 89 subjects included, 22 (24.7%) were positive for anti-PF4/heparin antibody. The correlations between antibody titer and either HEP or 4T scores were similar (r = 0.392, P < 0.01 for the HEP score; r = 0.444, P < 0.01 for the 4T score). No significant difference in the diagnostic performance was displayed between these two scores (AUC for the HEP score: 0.778 vs. AUC for the 4T score: 0.741, P = 0.357). Only 72 4T scores were collected from the residents, with a surprisingly low percentage of observers (43.1%) presenting the four individual item scores which made up their 4T score. The AUC of 4T score assessed by residents and hematologists was 0.657 (95% confidence interval [CI]: 536-0.765) and 0.780 (95% CI: 0.667-0.869, P < 0.05), respectively. The ICC of 4T score between residents and hematologists was 0.49 (95% CI: 0.29-0.65, P < 0.01), demonstrating a fair inter-observer agreement.

CONCLUSIONS

The HEP score does not display a better performance for predicting HIT than the 4T score. With the unsatisfactory completion rate, the inter-observer agreement of 4T score in a tertiary hospital is fair, underscoring the necessity for continuing education for physicians.

摘要

背景

肝素诱导的血小板减少症(HIT)的诊断具有挑战性。本研究旨在比较 HIT 专家概率(HEP)和 4T 评分的诊断性能,并评估 4T 评分在临床环境中的观察者间可靠性。

方法

这项前瞻性研究纳入了 2016 年至 2018 年间疑似 HIT 的患者。三位血液科医生评估了 HEP 和 4T 评分。评估了评分与抗血小板因子 4(抗 PF4)/肝素抗体之间的相关性。使用受试者工作特征曲线和曲线下面积(AUC)评估这两种评分模型的预测准确性。使用组内相关系数(ICC)评估住院医师和血液科医生之间 4T 评分的观察者间一致性。

结果

在 89 例受试者中,有 22 例(24.7%)抗 PF4/肝素抗体阳性。抗体滴度与 HEP 评分或 4T 评分之间的相关性相似(HEP 评分:r=0.392,P<0.01;4T 评分:r=0.444,P<0.01)。这两种评分之间的诊断性能无显著差异(HEP 评分的 AUC:0.778 与 4T 评分的 AUC:0.741,P=0.357)。仅从住院医师那里收集了 72 个 4T 评分,令人惊讶的是,只有 43.1%的观察者报告了构成其 4T 评分的四个单独项目评分。住院医师和血液科医生评估的 4T 评分 AUC 分别为 0.657(95%置信区间[CI]:0.536-0.765)和 0.780(95%CI:0.667-0.869,P<0.05)。住院医师和血液科医生之间的 4T 评分 ICC 为 0.49(95%CI:0.29-0.65,P<0.01),表明观察者间一致性尚可。

结论

HEP 评分在预测 HIT 方面的表现并不优于 4T 评分。由于完成率不理想,三级医院 4T 评分的观察者间一致性尚可,这突显了对医生进行继续教育的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/6629329/e32b4d33ae0c/cm9-132-1441-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/6629329/a0e989334a21/cm9-132-1441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/6629329/340ded77e2de/cm9-132-1441-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/6629329/e32b4d33ae0c/cm9-132-1441-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/6629329/a0e989334a21/cm9-132-1441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/6629329/340ded77e2de/cm9-132-1441-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/6629329/e32b4d33ae0c/cm9-132-1441-g004.jpg

相似文献

1
Prospective evaluation of heparin-induced thrombocytopenia expert probability and 4T scores in Chinese patients with suspected heparin-induced thrombocytopenia.疑似肝素诱导血小板减少症中国患者中肝素诱导血小板减少症专家概率和 4T 评分的前瞻性评估。
Chin Med J (Engl). 2019 Jun 20;132(12):1441-1447. doi: 10.1097/CM9.0000000000000261.
2
Evaluation of heparin induced thrombocytopenia using probability scores in a mechanical circulatory support population.使用机械循环支持人群中的概率评分评估肝素诱导的血小板减少症。
J Thromb Thrombolysis. 2019 Jul;48(1):134-140. doi: 10.1007/s11239-019-01843-8.
3
External validation of the HIT Expert Probability (HEP) score.血小板减少性紫癜专家概率(HEP)评分的外部验证
Thromb Haemost. 2015 Mar;113(3):633-40. doi: 10.1160/TH14-05-0472. Epub 2015 Jan 15.
4
Assessment of a modified 4T scoring system for heparin-induced thrombocytopenia in critically ill patients.评估改良4T评分系统在危重症患者肝素诱导的血小板减少症中的应用
J Crit Care. 2014 Jun;29(3):426-31. doi: 10.1016/j.jcrc.2013.12.010. Epub 2013 Dec 30.
5
Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia.临床医生教育对减少肝素诱导的血小板减少症中不适当 PF4 检测的影响有限。
J Thromb Thrombolysis. 2019 Feb;47(2):287-291. doi: 10.1007/s11239-018-01803-8.
6
Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing?内科中对肝素诱导的血小板减少症的怀疑:抗PF4/肝素抗体检测的医嘱开具的恰当性如何?
Platelets. 2015;26(7):632-7. doi: 10.3109/09537104.2014.965134. Epub 2014 Oct 2.
7
Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer.4T评分和肝素-血小板因子4抗体在癌症患者肝素诱导的血小板减少症(HIT)诊断中的表现
J Thromb Thrombolysis. 2017 Aug;44(2):261-266. doi: 10.1007/s11239-017-1523-z.
8
Interrater agreement for two systems used to determine the probability of heparin-induced thrombocytopenia.用于确定肝素诱导的血小板减少症概率的两种系统的评分者间一致性。
Am J Health Syst Pharm. 2014 Dec 1;71(23):2045-52. doi: 10.2146/ajhp130711.
9
Comparison of diagnostic performance of the heparin-induced thrombocytopenia expert probability and the 4Ts score in screening for heparin-induced thrombocytopenia.肝素诱导的血小板减少症专家概率与4Ts评分在肝素诱导的血小板减少症筛查中的诊断性能比较。
Blood Coagul Fibrinolysis. 2013 Apr;24(3):261-8. doi: 10.1097/MBC.0b013e32835baccb.
10
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的 HEP 评分与 4Ts 评分的前瞻性比较。
Blood Adv. 2018 Nov 27;2(22):3155-3162. doi: 10.1182/bloodadvances.2018023077.

本文引用的文献

1
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study.美国肝素诱导的血小板减少症的疾病负担、并发症发生率及医疗保健成本:一项基于人群的研究。
Lancet Haematol. 2018 May;5(5):e220-e231. doi: 10.1016/S2352-3026(18)30046-2.
2
Analysis of big data for heparin-induced thrombocytopenia: valuable information but also some doubts.肝素诱导的血小板减少症的大数据分析:有价值的信息但也存在一些疑问。
Lancet Haematol. 2018 May;5(5):e188-e189. doi: 10.1016/S2352-3026(18)30050-4.
3
Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL HIT-Ab] for the diagnosis of immune heparin-induced thrombocytopenia.
用于诊断免疫性肝素诱导的血小板减少症的自动化乳胶免疫比浊测定法(HemosIL HIT-Ab)的性能特征。
Thromb Res. 2017 May;153:108-117. doi: 10.1016/j.thromres.2017.03.010. Epub 2017 Mar 11.
4
Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York.利用4T评分法确定纽约州北部一家社区医院肝素诱导的血小板减少症的预检概率。
J Community Hosp Intern Med Perspect. 2016 Sep 7;6(4):32522. doi: 10.3402/jchimp.v6.32522. eCollection 2016.
5
Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的临床和实验室检查。
Thromb Haemost. 2016 Oct 28;116(5):823-834. doi: 10.1160/TH16-03-0240. Epub 2016 Sep 8.
6
A high-value cost conscious approach to minimize heparin induced thrombocytopenia antibody (HITAb) testing using the 4T score.一种采用4T评分的高价值、注重成本的方法,以尽量减少肝素诱导的血小板减少症抗体(HITAb)检测。
J Thromb Thrombolysis. 2016 Oct;42(3):441-6. doi: 10.1007/s11239-016-1396-6.
7
Assessing the clinical and cost impact of on-demand immunoassay testing for the diagnosis of heparin induced thrombocytopenia.评估按需免疫测定检测用于诊断肝素诱导的血小板减少症的临床和成本影响。
Thromb Res. 2016 Apr;140:155-162. doi: 10.1016/j.thromres.2016.01.025. Epub 2016 Feb 23.
8
Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test.与高光学密度抗血小板因子4酶联免疫吸附测定试验相关的临床和实验室特征。
J Blood Med. 2015 Nov 19;6:277-83. doi: 10.2147/JBM.S90179. eCollection 2015.
9
Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis.免疫测定在肝素诱导的血小板减少症诊断中的价值:系统评价和荟萃分析。
Blood. 2016 Feb 4;127(5):546-57. doi: 10.1182/blood-2015-07-661215. Epub 2015 Oct 30.
10
Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced Thrombocytopenia.用于肝素诱导的血小板减少症的IgG特异性酶联免疫吸附测定临界值0.4与0.8及1.0光密度单位的比较。
Clin Appl Thromb Hemost. 2017 Apr;23(3):282-286. doi: 10.1177/1076029615606532. Epub 2016 Jul 10.